Vanda Pharmaceuticals
VNDA
VNDA
138 hedge funds and large institutions have $212M invested in Vanda Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
97% less call options, than puts
Call options by funds: $197K | Put options by funds: $6.06M
Holders
138
Holding in Top 10
–
Calls
$197K
Puts
$6.06M
Top Buyers
| 1 | +$4.29M | |
| 2 | +$2.51M | |
| 3 | +$2.12M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.87M |
| 5 |
Two Sigma Investments
New York
|
+$1.54M |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$1.57M | |
| 3 | -$1.39M | |
| 4 |
Goldman Sachs
New York
|
-$1.26M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$882K |